PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
19621874-1	2009	(G:3-7)-dendri-PAMAM-(APO-Phe-Lys)(x) (2, APO = aminopropanol, Phe = phenylalanine, Lys = lysine) were prepared and used in a binding study with pyridoxal 5"-phosphate.	Propanolamines	48-61	aminopeptidase O (putative)	Homo sapiens	22-25
33921515-3	2021	The present study aimed to identify more virus-selective inhibitors of NTCP by screening of 87 propanolamine derivatives from the former development of intestinal bile acid reabsorption inhibitors (BARIs), which interact with the NTCP-homologous intestinal apical sodium-dependent bile acid transporter (ASBT).	Propanolamines	95-108	solute carrier family 10 member 1	Homo sapiens	71-75
33921515-3	2021	The present study aimed to identify more virus-selective inhibitors of NTCP by screening of 87 propanolamine derivatives from the former development of intestinal bile acid reabsorption inhibitors (BARIs), which interact with the NTCP-homologous intestinal apical sodium-dependent bile acid transporter (ASBT).	Propanolamines	95-108	solute carrier family 10 member 1	Homo sapiens	230-234
33921515-3	2021	The present study aimed to identify more virus-selective inhibitors of NTCP by screening of 87 propanolamine derivatives from the former development of intestinal bile acid reabsorption inhibitors (BARIs), which interact with the NTCP-homologous intestinal apical sodium-dependent bile acid transporter (ASBT).	Propanolamines	95-108	solute carrier family 10 member 2	Homo sapiens	304-308
23643911-1	2013	In this research, soft-binding aminopropanol (APP) was employed as an efficient ligand, for the transfer of as-prepared hydrophobic CdSe/ZnS quantum dots (QDs) into polar solvents.	Propanolamines	31-44	POC1 centriolar protein A	Homo sapiens	18-22
23643911-1	2013	In this research, soft-binding aminopropanol (APP) was employed as an efficient ligand, for the transfer of as-prepared hydrophobic CdSe/ZnS quantum dots (QDs) into polar solvents.	Propanolamines	46-49	POC1 centriolar protein A	Homo sapiens	18-22
23643911-4	2013	Taking advantage of the excellent solubility of the APP-capped QDs and the soft-binding characteristics of APP, a novel reaction-free method was investigated for the fluorescent labeling of polysaccharide-based micelles via encapsulation of the intermediate QDs.	Propanolamines	107-110	POC1 centriolar protein A	Homo sapiens	75-79
11602607-8	2001	In contrast, a psd1Delta psd2Delta strain, which makes low levels of PtdEtn from sphingolipid breakdown, can be rescued by ethanolamine, choline, or the ethanolamine analogue propanolamine.	Propanolamines	175-188	phosphatidylserine decarboxylase 1	Saccharomyces cerevisiae S288C	15-19
11602607-9	2001	psd1Delta psd2Delta cells grown in 2 mm propanolamine accumulate a novel lipid, which was determined by mass spectrometry to be phosphatidylpropanolamine (PtdPrn).	Propanolamines	40-53	phosphatidylserine decarboxylase 1	Saccharomyces cerevisiae S288C	0-4
9873746-0	1998	Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors.	Propanolamines	86-99	5-hydroxytryptamine receptor 1A	Homo sapiens	43-49
9873746-1	1998	Hybrid molecules built up by covalent coupling of aminopropanol derivatives (especially pindolol) with antidepressant drugs like fluoxetine, paroxetine or milnacipran were found to be potent and silent 5-HT1A antagonists (KB < 1 nM for 7c and 9a).	Propanolamines	50-63	5-hydroxytryptamine receptor 1A	Homo sapiens	202-208
6151379-0	1984	[Adrenergic beta 1 and beta 2 blocking activity of new aminopropanols derived from oximes and esters].	Propanolamines	55-69	potassium calcium-activated channel subfamily M regulatory beta subunit 2	Homo sapiens	0-29
18800760-1	2008	Enantiomeric propanolamines have been identified as a new class of NR2B-selective NMDA receptor antagonists.	Propanolamines	13-27	glutamate ionotropic receptor NMDA type subunit 2B	Homo sapiens	67-71
9871549-2	1998	Those isomers with different configuration on the center of chirality in the propanolamine side chain showed statistically different PGP-inhibitory activity.	Propanolamines	77-90	phosphoglycolate phosphatase	Homo sapiens	133-136